Circulating levels of a collagen type V propeptide fragment in a carbon tetrachloride reversible model of liver fibrosis

Biomarker Insights

Volumn 7, Issue , 2012, Pages 159-166

  Vassiliadis, E ^a,b   Veidal, S S ^a,b   Hansen, C ^a   Karsdal, M A ^a   Leeming, D J ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Biochemical markers; Liver fibrosis; Propeptide; Reversible carbon tetrachloride; Type V collagen

Indexed keywords

BIOLOGICAL MARKER; BIOTIN; CARBON TETRACHLORIDE; COLLAGEN TYPE 5; PEPTIDE FRAGMENT; STREPTAVIDIN;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; LIVER FIBROSIS; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RAT; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS;

ANIMALIA; RATTUS;

EID: 84871629345     PISSN: 11772719     EISSN: None     Source Type: Journal    
DOI: 10.4137/BMI.S10975     Document Type: Article

References (29)

1. Copple BL, Allen K, Welch TP. Mechanisms of liver fibrosis. Comprehensive Toxicology. 2010;9:263-274.
2. Vassiliadis E, Barascuk N, Didangelos A, Karsdal MA. Novel cardiac-specific biomarkers and the cardiovascular continuum. Biomark Insights. 2012;7:45-57.
3. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol. 2003; 38 Suppl 1:S38-S53.
4. Veidal SS, Vassiliadis E, Bay-Jensen AC, Tougas G, Vainer B, Karsdal MA. Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats. Fibrogenesis Tissue Repair. 2010;3(1):5.
5. Tanaka H, Leung PS, Kenny TP, Gershwin ME, Bowlus CL. Immunological Orchestration of Liver Fibrosis. Clin Rev Allergy Immunol. 2012;43(3):220-229.
6. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis. 2001;21(3):351-372.
7. Gomez-Aristizabal A, Ng C, Ng J, Davies JE. The effects of two mesenchymal cell populations on hepatocytes and lymphocytes. Liver Transpl. 2012;18(11):1384-1394.
8. Karsdal MA, Henriksen K, Leeming DJ, Woodworth T, Vassiliadis E, Bay-Jensen AC. Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers-are they the cause or the consequence of the disease?. Clin Biochem. 2010; 43(10-11):793-804.
9. Leeming DJ, Nielsen MJ, Dai Y, et al. Enzyme-linked immunosorbent serum assay specific for the 7S domain of Collagen Type IV (P4NP 7S): A marker related to the extracellular matrix remodeling during liver fibrogenesis. Hepatol Res. 2012;42(5):482-493.
10. Vassiliadis E, Larsen DV, Clausen RE, et al. Measurement of CO3-610, a potential liver biomarker derived from matrix metalloproteinase-9 degradation of collagen type III, in a rat model of reversible carbon- tetrachloride-induced fibrosis. Biomark Insights. 2011;6:49-58.
11. Veidal SS, Karsdal MA, Vassiliadis E, et al. MMP mediated degradation of type VI collagen is highly associated with liver fibrosis-identification and validation of a novel biochemical marker assay. PLoS One. 2011;6(9): e24753.
12. Leeming D, He Y, Veidal S, et al. A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M). Biomarkers. 2011;16(7):616-628.
13. Barascuk N, Veidal SS, Larsen L, et al. A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin Biochemistry. 2010;43(10-11):899-904.
14. Segovia-Silvestre T, Reichenbach V, Fernandez-Varo G, et al. Circulating CO3-610, a degradation product of collagen III, closely refects liver collagen and portal pressure in rats with fibrosis. Fibrogenesis Tissue Repair. Aug 3, 2011;4:19.
15. Veidal SS, Karsdal MA, Nawrocki A, et al. Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis. Fibrogenesis Tissue Repair. Oct 5, 2011; 4: 22.
16. Veidal SS, Bay-Jensen AC, Tougas G, Karsdal MA, Vainer B. Serum markers of liver fibrosis: combining the BIPED classification and the neo-epitope approach in the development of new biomarkers 14. Dis Markers. 2010;28(1):15-28.
17. Vassiliadis E, Veidal SS, Simonsen H, et al. Immunological detection of the type V collagen propeptide fragment, PVCP-1230, in connective tissue remodeling associated with liver fibrosis. Biomarkers. 2011;16(5): 426-433.
18. Fichard A, Kleman JP, Ruggiero F. Another look at collagen V and XI molecules. Matrix Biol. 1995;14(7):515-531.
19. Ruggiero F, Champliaud MF, Garrone R, Aumailley M. Interactions between cells and collagen V molecules or single chains involve distinct mechanisms. Exp Cell Res. 1994;210(2):215-223.
20. Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta. 2007;381(2):107-113.
21. Breuls RGM, Klumpers DD, Everts V, Smit TH. Collagen type V modulates fibroblast behaviour dependent on substrate stiffness. Biochem Biophys Res Commun. 2009;380(2):425-429.
22. Aycock RS, Seyer JM. Collagens of normal and cirrhotic human liver. Connect Tissue Res. 1989;23(1):19-31.
23. Choe I, Aycock RS, Raghow R, Myers JC, Seyer JM, Kang AH. A hepatic fibrogenic factor stimulates the synthesis of types I, III, and V procollagens in cultured cells. J Biol Chem. 1987;262(11):5408-5413.
24. Liang YR. Mechanism of fibroplasia in chronic active hepatitis. An immunohistochemical study of various collagen types, fibronectin and laminin in human liver. Chin Med J (Engl). 1989;102(1):53-59.
25. Takai KK, Hattori S, Irie S. Type V collagen distribution in liver is reconstructed in coculture system of hepatocytes and stellate cells; the possible functions of type V collagen in liver under normal and pathological conditions. Cell Struct Funct. Oct 2001;26(5):289-302.
26. Wenstrup RJ, Florer JB, Brunskill EW, Bell SM, Chervoneva I, Birk DE. Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem. Dec 17, 2004;279(51):53331-53337. Epub Sep 21, 2004.
27. Vassiliadis E, Veidal SS, Simonsen H, et al. Immunological detection of the type V collagen propeptide fragment, PVCP-1230, in connective tissue remodeling associated with liver fibrosis. Biomarkers. Aug 2011; 16(5):426-433. Epub May 25, 2011.
28. Segovia-Silvestre T, Reichenbach V, Ros J, et al. CO3-610, a novel non-invasive serum marker of liver fibrosis and portal hypertension in carbon tetrachloride-treated rats. 2010;1(8). In review. Ref Type: Generic.
29. Clarià J, Jimenez W. The Liver and the Kidney. In: Arroyo V, et al, editors. Renal Dysfunction and Ascites in Carbon Tetrachloride-Induced Cirrhosis in Rats. Blackwell Science, Boston; 1999:379-396.